Background The incidence of malignant mesothelioma in Germany is about 20 cases per
million persons per year. Its association with asbestos exposure, usually occupational, has …

Purpose To provide evidence-based recommendations to practicing physicians and others
on the management of malignant pleural mesothelioma. Methods ASCO convened an …

Background Several studies have already addressed the potential role of an increased
fluorine 18 fluorodeoxyglucose (18 F FDG) uptake in identification of pleural malignancy. In …

Malignant pleural mesothelioma (MPM) is a rare disease with a poor prognosis. The main
therapeutic options for MPM include surgery, chemotherapy, and radiation therapy (RT) …

Background: Optimal management of diffuse malignant pleural mesothelioma (DMPM)
remains unclear. We report our 30-year surgical experience with DMPM with emphasis on …

Objectives In this study, we aimed to investigate the factors affecting the survival of patients
with malignant pleural mesothelioma (MPM) according to their treatment schedules …

In malignant pleural mesothelioma (MPM) patients, local dissemination (LD) of the tumor is
frequently observed at the sites of intervention where diagnosis/treatment are performed. We …

An algorithm of preoperative mediastinal nodal staging with endobronchial/endoesophageal
ultrasonography (EBUS/EUS) and transcervical extended mediastinal lymphadenectomy …

OBJECTIVES: Measurement of tumor response to chemotherapy in malignant pleural
mesothelioma (MPM) is problematic because of non-spherical tumor growth patterns and …

Background This study aims to investigate patient-and disease characteristics associated
with survival in malignant pleural mesothelioma (MPM) patients with anti-tumor treatment or …